NEUROPACE INC. - COMMON STOCK

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

20 фев 2025 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

19 фев 2025 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

18 фев 2025 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

14 фев 2025 05:33:50 Источник Nasdaq GlobeNewswire

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

13 фев 2025 15:34:21 Источник Nasdaq GlobeNewswire

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

03 фев 2025 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Issues 2025 Financial Guidance Targets

28 янв 2025 16:15:59 Источник Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

08 янв 2025 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

18 дек 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace to Host Investor Day on January 28th in New York City

12 дек 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

04 дек 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

03 дек 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

12 ноя 2024 15:05:01 Источник Nasdaq GlobeNewswire

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

04 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

22 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Continues to Strengthen Management Team

16 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Strengthens Management Team with Two Key Appointments

04 сен 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

27 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Healthcare Conferences in September

22 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

13 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire